Published in J Clin Invest on May 01, 1990
The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest (1991) 1.66
Platelet adhesion under flow. Microcirculation (2009) 1.31
Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun (2014) 1.03
Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood. J Clin Invest (1994) 0.96
Studies of activated GPIIb/IIIa receptors on the luminal surface of adherent platelets. Paradoxical loss of luminal receptors when platelets adhere to high density fibrinogen. J Clin Invest (1993) 0.87
Proteins, platelets, and blood coagulation at biomaterial interfaces. Colloids Surf B Biointerfaces (2014) 0.79
Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs- CRP With Disease Severity in Coronary Artery Disease. J Cardiovasc Thorac Res (2015) 0.75
Platelets Proteomic Profiles of Acute Ischemic Stroke Patients. PLoS One (2016) 0.75
Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts. PLoS One (2014) 0.75
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun (1978) 32.33
Integrins: a family of cell surface receptors. Cell (1987) 21.14
Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors. Science (1986) 5.58
Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci U S A (1987) 4.17
The platelet membrane glycoprotein IIb-IIIa complex. Blood (1988) 4.17
Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest (1979) 4.12
Gel filtration. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh (1971) 4.08
Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem (1979) 3.61
Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci U S A (1983) 3.23
A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest (1983) 3.05
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Cell attachment to thrombospondin: the role of ARG-GLY-ASP, calcium, and integrin receptors. J Cell Biol (1988) 2.72
Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J (1985) 2.69
Specific and saturable binding of plasma fibronectin to thrombin-stimulated human platelets. J Biol Chem (1981) 2.31
Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood (1980) 2.22
Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody. Proc Natl Acad Sci U S A (1983) 2.09
An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin. Blood (1989) 2.05
A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci U S A (1985) 2.04
Related binding mechanisms for fibrinogen, fibronectin, von Willebrand factor, and thrombospondin on thrombin-stimulated human platelets. Blood (1985) 1.95
Interaction of fibronectin with its receptor on platelets. Cell (1985) 1.92
Role of thrombospondin in platelet aggregation. J Clin Invest (1984) 1.86
Evidence that three adhesive proteins interact with a common recognition site on activated platelets. J Biol Chem (1984) 1.83
Immunochemical and amino-terminal sequence comparison of two cytoadhesins indicates they contain similar or identical beta subunits and distinct alpha subunits. J Biol Chem (1987) 1.82
Molecular defects in interactions of platelets with the vessel wall. N Engl J Med (1984) 1.78
Arachidonic acid-induced human platelet aggregation and prostaglandin formation. Prostaglandins (1973) 1.69
Isolation of human serum spreading factor. J Biol Chem (1983) 1.61
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets. J Clin Invest (1982) 1.59
Molecular cloning of S-protein, a link between complement, coagulation and cell-substrate adhesion. EMBO J (1985) 1.56
Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry (1985) 1.48
The lumi-aggregometer: a new instrument for simultaneous measurement of secretion and aggregation by platelets. J Lab Clin Med (1977) 1.40
The SC5b-7 complex: formation, isolation, properties, and subunit composition. J Immunol (1977) 1.35
Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments. J Clin Invest (1975) 1.32
Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem (1988) 1.32
Fibrinogen receptor exposure and aggregation of human blood platelets produced by ADP and chilling. Blood (1981) 1.21
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood (1984) 1.21
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Antibodies against a 23Kd heparin binding fragment of thrombospondin inhibit platelet aggregation. Biochem Biophys Res Commun (1984) 1.16
Localization of vitronectin (S-protein of complement) in normal human skin. Acta Derm Venereol (1986) 1.12
Isolation and characterization of a platelet membrane protein related to the vitronectin receptor. J Biol Chem (1989) 1.12
Inhibition of platelet aggregation by a monoclonal antibody against human fibronectin. Proc Natl Acad Sci U S A (1985) 1.06
Association of thrombin-antithrombin III complex with vitronectin in serum. J Biol Chem (1985) 0.98
Effect of complement proteins C5b-9 on blood platelets. Evidence for reversible depolarization of membrane potential. J Biol Chem (1985) 0.98
Interaction of complement S-protein with thrombin-antithrombin complexes: a role for the S-protein in haemostasis. Thromb Res (1985) 0.93
Interaction of S-protein of complement with thrombin and antithrombin III during coagulation. Protection of thrombin by S-protein from antithrombin III inactivation. J Biol Chem (1986) 0.90
Binding of fibronectin to alpha-granule-deficient platelets. J Cell Biol (1983) 0.89
Vitronectin at sites of cell-substrate contact in cultures of rat myotubes. J Cell Biol (1986) 0.77
Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur J Immunol (1995) 1.62
Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J (1997) 1.42
Efficient ex vivo inhibition of perforin and Fas ligand expression by chimeric tRNA-hammerhead ribozymes. Hum Gene Ther (1998) 1.40
Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue. Am J Pathol (1987) 1.33
Azidothymidine and interferon-alpha induce apoptosis in herpesvirus-associated lymphomas. Cancer Res (1999) 0.96
Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis. J Exp Med (1990) 0.91
A hammerhead ribozyme that cleaves perforin and fas-ligand RNAs in vitro. Biochem Biophys Res Commun (1996) 0.80
Erythropoiesis in cancer patients undergoing immunotherapy. Adv Exp Med Biol (1989) 0.78
Phase I study of transfected cancer cells expressing the interleukin-2 gene product in limited stage small cell lung cancer. Hum Gene Ther (1995) 0.77
Proposal for classification of leukocyte-associated cytolytic molecules: Denver, Colorado, September 28, 1986. J Leukoc Biol (1987) 0.75
Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells. J Cancer Res Clin Oncol (1989) 0.75
Mechanisms of rejection of nonvascularized grafts: the role of perforin and Fas. Transplant Proc (1997) 0.75
In vitro characterization of hammerhead ribozymes against perforin and fas-ligand RNA. Transplant Proc (1997) 0.75
Cellular interactions in hemopoiesis. Blood Cells (1987) 0.75
Molecular events in late stages of T-cell functional maturation. Scand J Immunol (1992) 0.75